Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 3Plasma cell 2Head & Neck 2CNS 2Breast 2

Conditions

cyclopia sequence 1Oropharyngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 263Radiotherapy 166Cetuximab 159Docetaxel 105Fluorouracil 104pembrolizumab 94Radiotherapy, Intensity-Modulated 83Carboplatin 80Paclitaxel 73Nivolumab 59Erlotinib Hydrochloride 35Surveys and Questionnaires 32Gemcitabine 32durvalumab 30Radiation 29Drug Therapy 25Immunohistochemistry 21Gefitinib 21Capecitabine 21tremelimumab 18Bevacizumab 18Surgical Procedures, Operative 17Sorafenib 17Magnetic Resonance Spectroscopy 17Ipilimumab 17Pemetrexed 16lenvatinib 15atezolizumab 15Radiosurgery 15Gene Expression Profiling 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Minocycline × Head & Neck × Clear all
NCT04721626 2022-02-07

Topical Antisepsis in Head and Neck Cancer Surgery

Medical College of Wisconsin

Completed
25 enrolled
Head & Neck

Head and Neck Neoplasms

NCT01173692 2021-08-20

Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study.

M.D. Anderson Cancer Center

Phase 2 Completed
47 enrolled 7 charts
Head & Neck

cyclopia sequence, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡